ArticleMolecular therapy. Methods & clinical development2021

Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys.

Julien Baruteau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.